FDA

14°

Weather

YnetGlobal Channels

Sites & Sources

more channels

Contact

FDA

FDA rejects use of MDMA for PTSD

Advisory Committee says it is concerned over allegations of inappropriate sexual behavior during a clinical trial and the potential for severe health risks after taking the drug

News Agencies, Daniel Edelson, New York | 08.11.24

Study reveals presence of toxic metals in tampons

The FDA regulates tampons as medical devices but does not require testing for chemical contaminants

Ynetnews | 07.18.24

Alzheimer drug gets unanimous approval from FDA panel

Lilly's donanemab, Alzheimer's drug benefits outweigh risks in the early stages of the disease although it causes brain swelling and bleeding; the panel finds, clearing the way for a final FDA decision

Reuters | 06.11.24

FDA panel rejects initial MDMA therapy for PTSD

Board criticizes ability of participants to accurately guess if they received MDMA or placebo, potentially skewing results

Ynetnews | 06.05.24

Israeli weight-loss pill stock soars despite detail-free announcement

Israel's Epitomee Medical announced a successful trial for its weight-loss pill; Despite not disclosing the results involving 279 participants, the company's stock rose by 80% at the end of the trading day

Adiel Eithan Mustaki | 09.05.23

FDA approves vaccinating pregnant women against RSV to protect fetus

FDA approves Abrysvo vaccine for pregnant women between weeks 32 and 36 of their pregnancy to protect their unborn child, as the antibodies will provide crucial protection for at least six months – a critical period during which any simple infection can potentially endanger the infant's life

Dr. Itay Gal | 08.23.23

Postpartum depression: 'It's not enough just to take a pill – social support is needed'

In Israel, 13% of postpartum women suffer from depression and, despite a newly approved drug by the FDA, medication alone is not sufficiently effective

Attila Somfalvi | 08.10.23

FDA approves RSV vaccine for infants

Respiratory Syncytial Virus poses danger to infants under the age of one and the at risk population; new vaccine administered in one shot found to reduce hospitalization by 70% according to studies

Prof. Malena Cohen-Cymberknoh | 07.24.23

Psychedelic treatment for mental health: Will Israel embrace the Australian approach?

Australia permitted psychiatrists to prescribe ecstasy and psilocybin mushrooms for the treatment of depression and PTSD, raising a heated debate: Is this safe? Who is it suitable for? What are the implications? And what are the chances of this being approved in Israel next?

Dr. Itay Gal | 07.17.23

Alzheimer's drug gives hope to Israeli patients and their families

After Leqembi receives accelerated approval of the FDA medical experts say cure is a gamechanger, calling on doctors, HMOs to invest more in early detection

Adir Yanko | 07.09.23

What are the chances aspartame is cancerous, and how bad are sweetners really?

The expected announcement in two weeks about the artificial sweetener aspartame found in diet beverages and other foods, claiming it may be a potential carcinogen, is already causing a global uproar; How dangerous is the substance, and is there a reason to panic?

Dr. Itay Gal | 07.02.23

Israel FDA branch greenlight just around the corner in boon for local industry

U.S. food and drug regulator opening office in Israel would help reduce red tape in development of new biomedicine products and devices, saving companies millions

Daniel Edelson, New York | 05.18.23

Israel in race for next big weight loss medication

Ozempic, the famous injection for treating obesity that has been so difficult to obtain, will soon become old news, as the pharmaceutical industry is working tirelessly on the next generation of drugs, so what's on the menu?

The Atlantic, Yasmin Tiag | 05.03.23

Previous Articles

Hot Tags

Today

This Week

This Month

Judicial reform Ahmad al-Sharaa Airstrike Amsterdam Antisemitism Ariel Bibas Benjamin Netanyahu Bitcoin Climate crisis Columbia University

Hot Tags

Today

This Week

This Month

Judicial reform Ahmad al-Sharaa Airstrike Amsterdam Antisemitism Ariel Bibas Benjamin Netanyahu Bitcoin Climate crisis Columbia University